Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...

A rash may occur after you contract HIV. It commonly appears on the face and chest but can also appear in other places. Medications used to treat HIV as well as certain infections may also cause ...